Antiproliferative effect and apoptotic response in vitro of human melanoma cells to liposomes containing the ribosome-inactivating protein luffin

Biochimica et Biophysica Acta - General Subjects

Volumn 1472, Issue 1-2, 1999, Pages 197-205

  Poma, Anna ^a   Marcozzi, Giordana ^a   Cesare, Patrizia ^a   Carmignani, Marco ^a   Spanò, Laura ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Liposome; Luffin; Melanoma; Ribosome Inactivating Protein

Indexed keywords

CHOLESTEROL; LIPOSOME; PHOSPHATIDYLCHOLINE; RIBOSOME INACTIVATING PROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID COMPOSITION; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

APOPTOSIS; DRUG CARRIERS; HUMANS; KINETICS; LIPOSOMES; MELANOMA; MICROSCOPY, ELECTRON, SCANNING; PLANT PROTEINS; PROTEIN SYNTHESIS INHIBITORS; RIBOSOMAL PROTEINS; TUMOR CELLS, CULTURED;

EID: 0032828394     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(99)00121-X     Document Type: Article

References (22)

1. Wick R., Luisi P.L. Enzyme-containing liposomes can endogenously produce membrane-constituting lipids. Chem. Biol. 3:1996;277-285.
2. Monnard P.A., Oberholzer T., Luisi P.L. Entrapment of nucleic acid in liposomes. Biochim. Biophys. Acta. 1329:1997;39-50.
3. Allen T.M., McAllister L., Mausolf S., Gyoffry E. Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anti-cancer drugs with the EM T6, S49 and AE (transport-deficient) cell lines. Biochim. Biophys. Acta. 643:1981;346-362.
4. T. Nagata, Liposome entrapment for delivery of genetic material to plant protoplasts, in: R. Green, K.J. Widder (Eds.), Methods in Enzymology, vol. 149, Drug and Enzyme Targeting, Academic Press, San Diego, 1987, pp. 176-184.
5. Kirjavainen M., Urtti A., Jaaskelainen I., Marjiukka Suhonen T., Paronen P., Valjakka-Koskela R., Kiesvaara J., Monkkonen J. Interaction of liposomes with human skin in vitro - the influence of lipid composition and structure. Biochim. Biophys. Acta. 1304:1996;179-189.
6. Ahmad I., Filep J.J., Franklin J.C., Janoff A.S., Masters G.R., Pattassery J., Peters A., Schupsky J.J., Zha Y., Mayhew E. Enhanced therapeutic effects of liposome-associated 1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphocholine. Cancer Res. 57:1997;1915-1921.
7. Caplen N.J., Alton E.F.W., Middleton P.G., Dorin J.R., Stevenson B.J., Gao X., Durham S.R., Jeffery P.K. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat. Med. 1:1995;39-46.
8. Hartley M.R., Chaddock J.A., Bonnes M.S. The structure and function of ribosome-inactivating proteins. Trends Plant Sci. 1:(3):1985;254-259.
9. Barbieri L., Battelli M.G., Stirpe F. Ribosome-inactivating proteins from planta. Biochim. Biophys. Acta. 1154:1993;273-282.
10. Girbes T., Ferreras J.M., Iglesias R., Citore L., De Torre C., Carbajales M.L., Jiménez P., De Benito F.M., Munoz R. Recent advances in the uses and applications of ribosome-inactivating proteins from planta. Cell. Mol. Biol. 42:1996;461-471.
11. Kamenosono N., Nishida H., Funatsu G. Isolation and characterization of two luffin, protein biosynthesis inhibitory proteins from the seeds of Luffa cylindrica. Agric. Biol. Chem. 52:1988;1223-1227.
12. Poma A., Galeota K., Miranda M., Spanò L. A ribosome-inactivating protein principle from hairy roots and seeds of Luffa cylindrica (L) Roem and its cytotoxicity on melanotic and amelanotic melanoma cell lines. Int. J. Pharmacognosy. 35:(3):1997;212-214.
13. Poma A., Miranda M., Spanò L. Differential response of human melanoma and Ehrlich ascites cells in vitro to the ribosome-inactivating protein luffin. Melanoma Res. 8:1998;465-467.
14. Hao Q., Yan L., Yang H., Zhang Y., Gao G., Yao Q., Li Q. Aggregation of phospholipid vesicles induced by the ribosome inactivating protein saporin. Biochem. Mol. Biol. Int. 36:(4):1996;701-709.
15. Hao Q., Ding T., Zhang Y., Liu G., Gao G., Yan G., Yao Q., Li Q. Fluorescence spectroscopic study of the interaction of saporin with phospholipid vesicles. Mol. Membr. Biol. 14:(1):1997;19-23.
16. McIntosh D., Heath T.D. Liposome-mediated delivery of ribosome inactivating proteins to cells in vitro. Biochim. Biophys. Acta. 690:1982;224-230.
17. Marcozzi G., Spanò L. A simple method for the purification of type I RIPs. Biomed. Chromatogr. 11:1997;151-153.
18. Szoka F., Olson F., Heath T., Vail W., Mayhew E., Papahadjopoulos D. Preparation of unilamellar liposomes of intermediate size by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim. Biophys. Acta. 601:1980;559-571.
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;442-444.
20. Collins R.J., Harmon B.V., Souvlis T., Pope J.K., Kerr J.F.R. Effects of cycloheximide on B-chronic lymphocytic leukaemic and normal lymphocytes in vitro: induction of apoptosis. Br. J. Cancer. 64:1991;518-522.
21. Tecce R., Nicotra M.R., Fraiali R., Cuomo M., Trizio D., Natali P.G. Saporin 6 conjugated to monoclonal antibody selectively kills human melanoma cells. Melanoma Res. 1:1991;115-123.
22. Ling J., Liu W.Y. Cytotoxicity of two new ribosome-inactivating proteins, cinnamomin and camphorin, to carcinoma cells. Cell Biochem. Funct. 14:(3):1996;157-161.